Kabbani Dima, Orenbuch-Harroch Efrat, Boodman Carl, Broad Sarah, Paz-Infanzon Manuel, Belga Sara, Fernández-García Oscar A, Christie Emily, L N Sikosana Majid, Shojai Soroush, Gourishankar Sita, Cervera Carlos, Doucette Karen
Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Am J Transplant. 2025 Feb;25(2):417-423. doi: 10.1016/j.ajt.2024.09.026. Epub 2024 Sep 24.
Bartonella quintana infection is rarely described to be transmitted through solid organ transplant (SOT). We report a cluster of using donor-derived B quintana infection and the attack rate from Bartonella seropositive donors. In this retrospective study of SOT recipients that received an organ from an unhoused deceased donor (UDD) in Alberta in 2022-2023, serology testing for Bartonella was performed indirect immunofluorescent assay on UDDs and recipients of UDDs with positive serology. Titers ≥1:64 were considered positive. During the study period, 31/32 UDDs were tested for immunoglobulin G to Bartonella (20 negative, 11 positive for B quintana and/or B henselae). Thirty-two organs were transplanted from the 11 seropositive donors. Six SOT recipients developed bartonellosis secondary to B quintana (4 SOT recipients received organs from 3 seropositive donors, and 2 SOT recipients from 1 UDD with no stored sample for testing). The attack rate for clinical disease from positive donors was 12.5% (4/32). The main presentation was skin nodules/papules (median 5.5 months) with bacillary angiomatosis in 4/6. Bartonella serology was positive in 5/6 SOT recipients (initially negative in 2) and blood B quintana quantitative polymerase chain reaction in 1. None had visceral involvement. All donors had history of substance use. This outbreak of bartonellosis reinforces the potential for unexpected donor-transmitted infections. Clinicians should be aware of high transmission of B quintana through transplant from infected UDDs.
五日热巴尔通体感染很少被描述为通过实体器官移植(SOT)传播。我们报告了一组由供体来源的五日热巴尔通体感染病例以及来自巴尔通体血清学阳性供体的感染率。在这项对2022 - 2023年在艾伯塔省接受来自无家可归的已故供体(UDD)器官的SOT受者的回顾性研究中,对UDD以及血清学阳性的UDD受者进行了间接免疫荧光法检测巴尔通体血清学。滴度≥1:64被视为阳性。在研究期间,对31/32名UDD进行了抗巴尔通体免疫球蛋白G检测(20名阴性,11名五日热巴尔通体和/或亨氏巴尔通体阳性)。从11名血清学阳性供体移植了32个器官。6名SOT受者继发五日热巴尔通体感染(4名SOT受者接受了来自3名血清学阳性供体的器官,2名SOT受者接受了来自1名无储存样本可供检测的UDD的器官)。来自阳性供体的临床疾病感染率为12.5%(4/32)。主要表现为皮肤结节/丘疹(中位时间5.5个月),4/6伴有杆菌性血管瘤。6名SOT受者中有5名巴尔通体血清学呈阳性(2名最初为阴性),1名血液五日热巴尔通体定量聚合酶链反应呈阳性。均无内脏受累。所有供体都有药物使用史。这次巴尔通体病的爆发强化了意外的供体传播感染的可能性。临床医生应意识到通过移植来自受感染UDD的器官传播五日热巴尔通体的高风险。